Current treatments for axillary hyperhidrosis
Primary hyperhidrosis affects up to 1% of the population and has a significant negative impact on quality of life. It affects the axillae in approximately 80% of cases. Hyperhidrosis results from excessive sympathetic stimulation of the eccrine sweat glands: the various treatment modalities availabl...
Gespeichert in:
| Veröffentlicht in: | The surgeon (Edinburgh) 2004-12, Vol.2 (6), p.311-314 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 314 |
|---|---|
| container_issue | 6 |
| container_start_page | 311 |
| container_title | The surgeon (Edinburgh) |
| container_volume | 2 |
| creator | Fitzgerald, E. Feeley, T.M. Tierney, S. |
| description | Primary hyperhidrosis affects up to 1% of the population and has a significant negative impact on quality of life. It affects the axillae in approximately 80% of cases. Hyperhidrosis results from excessive sympathetic stimulation of the eccrine sweat glands: the various treatment modalities available target points along the pathway between the central nervous system and the peripheral gland. The first line of treatment is topical aluminium chloride, which is effective in the majority of cases. Alternative treatments such as systemic anti-cholinergics and iontophoresis have significant disadvantages, while surgical sympathectomy has been regarded as the gold-standard in treatment of this condition. Recently, attention has focused on the use of intradermal botulinum toxin for the treatment of axillary hyperhidrosis. This is a highly effective, minimally-invasive treatment with few side effects, and is now recommended as the treatment of choice in isolated axillary hyperhidrosis |
| doi_str_mv | 10.1016/S1479-666X(04)80028-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67262387</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1479666X04800283</els_id><sourcerecordid>67262387</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-d53fe407d49483bdd9e63d9c77972093252f56c258f639a928fc63e51f0a2c1f3</originalsourceid><addsrcrecordid>eNqFkMtKAzEUQIMotlY_QelG0cVo3jNZiRRfUHChgruQJjc0MtOpyVTs35s-sEtXuYtzbw4HoVOCrwkm8uaV8FIVUsqPS8yvKoxpVbA91Kcci0JUHO-j_h_SQ0cpfWZGMCwOUY-IklAhVR8Vo0WMMOuGXQTTNXlKQ9_GofkJdW3icjhdziFOg4ttCukYHXhTJzjZvgP0_nD_Nnoqxi-Pz6O7cWGZYl3hBPPAcem44hWbOKdAMqdsWaqSYsWooF5IS0XlJVNG0cpbyUAQjw21xLMButjcncf2awGp001IFrLRDNpF0rKkkrKqzKDYgDb7pQhez2NosrcmWK866XUnvYqgMdfrTprlvbPtB4tJA263tQ2TgfMtYJI1tY9mZkPacdmbcbo6dLvhIOf4DhB1sgFmFlyIYDvt2vCPyi8mSYQu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67262387</pqid></control><display><type>article</type><title>Current treatments for axillary hyperhidrosis</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Fitzgerald, E. ; Feeley, T.M. ; Tierney, S.</creator><creatorcontrib>Fitzgerald, E. ; Feeley, T.M. ; Tierney, S.</creatorcontrib><description>Primary hyperhidrosis affects up to 1% of the population and has a significant negative impact on quality of life. It affects the axillae in approximately 80% of cases. Hyperhidrosis results from excessive sympathetic stimulation of the eccrine sweat glands: the various treatment modalities available target points along the pathway between the central nervous system and the peripheral gland. The first line of treatment is topical aluminium chloride, which is effective in the majority of cases. Alternative treatments such as systemic anti-cholinergics and iontophoresis have significant disadvantages, while surgical sympathectomy has been regarded as the gold-standard in treatment of this condition. Recently, attention has focused on the use of intradermal botulinum toxin for the treatment of axillary hyperhidrosis. This is a highly effective, minimally-invasive treatment with few side effects, and is now recommended as the treatment of choice in isolated axillary hyperhidrosis</description><identifier>ISSN: 1479-666X</identifier><identifier>EISSN: 2405-5840</identifier><identifier>DOI: 10.1016/S1479-666X(04)80028-3</identifier><identifier>PMID: 15712569</identifier><language>eng</language><publisher>Edinburgh: Elsevier Ltd</publisher><subject>Axilla ; Biological and medical sciences ; Dermatology ; General aspects ; Humans ; Hyperhidrosis ; Hyperhidrosis - drug therapy ; Hyperhidrosis - surgery ; Medical sciences ; Skin involvement in other diseases. Miscellaneous. General aspects</subject><ispartof>The surgeon (Edinburgh), 2004-12, Vol.2 (6), p.311-314</ispartof><rights>2004 Royal College of Surgeons of Edinburgh and Royal College of Surgeons in Ireland</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-d53fe407d49483bdd9e63d9c77972093252f56c258f639a928fc63e51f0a2c1f3</citedby><cites>FETCH-LOGICAL-c393t-d53fe407d49483bdd9e63d9c77972093252f56c258f639a928fc63e51f0a2c1f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S1479-666X(04)80028-3$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16393423$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15712569$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fitzgerald, E.</creatorcontrib><creatorcontrib>Feeley, T.M.</creatorcontrib><creatorcontrib>Tierney, S.</creatorcontrib><title>Current treatments for axillary hyperhidrosis</title><title>The surgeon (Edinburgh)</title><addtitle>Surgeon</addtitle><description>Primary hyperhidrosis affects up to 1% of the population and has a significant negative impact on quality of life. It affects the axillae in approximately 80% of cases. Hyperhidrosis results from excessive sympathetic stimulation of the eccrine sweat glands: the various treatment modalities available target points along the pathway between the central nervous system and the peripheral gland. The first line of treatment is topical aluminium chloride, which is effective in the majority of cases. Alternative treatments such as systemic anti-cholinergics and iontophoresis have significant disadvantages, while surgical sympathectomy has been regarded as the gold-standard in treatment of this condition. Recently, attention has focused on the use of intradermal botulinum toxin for the treatment of axillary hyperhidrosis. This is a highly effective, minimally-invasive treatment with few side effects, and is now recommended as the treatment of choice in isolated axillary hyperhidrosis</description><subject>Axilla</subject><subject>Biological and medical sciences</subject><subject>Dermatology</subject><subject>General aspects</subject><subject>Humans</subject><subject>Hyperhidrosis</subject><subject>Hyperhidrosis - drug therapy</subject><subject>Hyperhidrosis - surgery</subject><subject>Medical sciences</subject><subject>Skin involvement in other diseases. Miscellaneous. General aspects</subject><issn>1479-666X</issn><issn>2405-5840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtKAzEUQIMotlY_QelG0cVo3jNZiRRfUHChgruQJjc0MtOpyVTs35s-sEtXuYtzbw4HoVOCrwkm8uaV8FIVUsqPS8yvKoxpVbA91Kcci0JUHO-j_h_SQ0cpfWZGMCwOUY-IklAhVR8Vo0WMMOuGXQTTNXlKQ9_GofkJdW3icjhdziFOg4ttCukYHXhTJzjZvgP0_nD_Nnoqxi-Pz6O7cWGZYl3hBPPAcem44hWbOKdAMqdsWaqSYsWooF5IS0XlJVNG0cpbyUAQjw21xLMButjcncf2awGp001IFrLRDNpF0rKkkrKqzKDYgDb7pQhez2NosrcmWK866XUnvYqgMdfrTprlvbPtB4tJA263tQ2TgfMtYJI1tY9mZkPacdmbcbo6dLvhIOf4DhB1sgFmFlyIYDvt2vCPyi8mSYQu</recordid><startdate>20041201</startdate><enddate>20041201</enddate><creator>Fitzgerald, E.</creator><creator>Feeley, T.M.</creator><creator>Tierney, S.</creator><general>Elsevier Ltd</general><general>Royal College of Surgeons of Edinburgh</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041201</creationdate><title>Current treatments for axillary hyperhidrosis</title><author>Fitzgerald, E. ; Feeley, T.M. ; Tierney, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-d53fe407d49483bdd9e63d9c77972093252f56c258f639a928fc63e51f0a2c1f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Axilla</topic><topic>Biological and medical sciences</topic><topic>Dermatology</topic><topic>General aspects</topic><topic>Humans</topic><topic>Hyperhidrosis</topic><topic>Hyperhidrosis - drug therapy</topic><topic>Hyperhidrosis - surgery</topic><topic>Medical sciences</topic><topic>Skin involvement in other diseases. Miscellaneous. General aspects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fitzgerald, E.</creatorcontrib><creatorcontrib>Feeley, T.M.</creatorcontrib><creatorcontrib>Tierney, S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The surgeon (Edinburgh)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fitzgerald, E.</au><au>Feeley, T.M.</au><au>Tierney, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current treatments for axillary hyperhidrosis</atitle><jtitle>The surgeon (Edinburgh)</jtitle><addtitle>Surgeon</addtitle><date>2004-12-01</date><risdate>2004</risdate><volume>2</volume><issue>6</issue><spage>311</spage><epage>314</epage><pages>311-314</pages><issn>1479-666X</issn><eissn>2405-5840</eissn><abstract>Primary hyperhidrosis affects up to 1% of the population and has a significant negative impact on quality of life. It affects the axillae in approximately 80% of cases. Hyperhidrosis results from excessive sympathetic stimulation of the eccrine sweat glands: the various treatment modalities available target points along the pathway between the central nervous system and the peripheral gland. The first line of treatment is topical aluminium chloride, which is effective in the majority of cases. Alternative treatments such as systemic anti-cholinergics and iontophoresis have significant disadvantages, while surgical sympathectomy has been regarded as the gold-standard in treatment of this condition. Recently, attention has focused on the use of intradermal botulinum toxin for the treatment of axillary hyperhidrosis. This is a highly effective, minimally-invasive treatment with few side effects, and is now recommended as the treatment of choice in isolated axillary hyperhidrosis</abstract><cop>Edinburgh</cop><pub>Elsevier Ltd</pub><pmid>15712569</pmid><doi>10.1016/S1479-666X(04)80028-3</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1479-666X |
| ispartof | The surgeon (Edinburgh), 2004-12, Vol.2 (6), p.311-314 |
| issn | 1479-666X 2405-5840 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67262387 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Axilla Biological and medical sciences Dermatology General aspects Humans Hyperhidrosis Hyperhidrosis - drug therapy Hyperhidrosis - surgery Medical sciences Skin involvement in other diseases. Miscellaneous. General aspects |
| title | Current treatments for axillary hyperhidrosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T18%3A17%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20treatments%20for%20axillary%20hyperhidrosis&rft.jtitle=The%20surgeon%20(Edinburgh)&rft.au=Fitzgerald,%20E.&rft.date=2004-12-01&rft.volume=2&rft.issue=6&rft.spage=311&rft.epage=314&rft.pages=311-314&rft.issn=1479-666X&rft.eissn=2405-5840&rft_id=info:doi/10.1016/S1479-666X(04)80028-3&rft_dat=%3Cproquest_cross%3E67262387%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67262387&rft_id=info:pmid/15712569&rft_els_id=S1479666X04800283&rfr_iscdi=true |